2-((7-(3,4-Dimethoxyphenyl)quinoxalin-2-yl)amino)-N-methylacetamide, 98%, 10mg

5-Chloropyrazolo[1,5-a]pyridine, 95.0%, 1g

4-n-Decyloxybenzoic acid, 99.0%, 25g

4-(Piperidin-4-yl)thiomorpholine 1,1-dioxide dihydrochloride, 95.0%, 250mg

1,4-Bis((1H-imidazol-1-yl)methyl)benzene, 95.0%, 5g

(7s)-7-Methyl-1,3,4,6,7,8,9,9a-octahydropyrazino[2,1-c][1,4]oxazine, 98%, 1g

1H-imidazo[4,5-b]pyrazin-2-amine, 98%, 1g

2-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 100mg

3-Bromo-2,6-difluorobenzonitrile, 97%, 10g

N-(5-Guanidino-1-((4-nitrophenyl)amino)-1-oxopentan-2-yl)benzamide hydrochloride, 97.0%, 5g

2-METHYL-5-PHENYLOXAZOLE, 97.0%, 1g

Tapón de llave de paso, 14,5, 4,0 mm, 2 Pieza(s)

4-(N-TERT-BUTOXYCARBONYLHYDRAZINO)BENZOIC ACID ETHYL ESTER, 95.0%, 10g